http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2699506-C1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_5f220ff41ebe4c7f2e7da8ec7e7e9dca |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-546 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P27-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61F9-007 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P27-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-546 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61F9-007 |
| filingDate | 2018-11-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2019-09-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_aeb384cd37431fa31c741d552c3c73df http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_556dca10a6f8a20b64c0e7cfaf35ba42 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_821251e33fdaf03f9fafee3fad7644e6 |
| publicationDate | 2019-09-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | RU-2699506-C1 |
| titleOfInvention | Method of differentiated approach to treatment of acute postoperative endophthalmitis |
| abstract | FIELD: medicine.SUBSTANCE: invention refers to medicine, namely to ophthalmology, and can be used for a differentiated approach to treating acute postoperative endophthalmitis. A standard three-port vitrectomy is performed with posterior capsular lens dyslexia, exudate removal from an anterior chamber and a vitreous body cavity, and additional introduction of 1 mg of vancomycin and 2,25 mg of ceftazidime by an intravitreal injection at the end of the operation. Depending on degree of manifestation of inflammatory reaction of eye, which is qualitatively evaluated by biomicroscopy, and quantitatively – according to protein flow in anterior chamber: with light degree of 25 to 79 f/ms – filling vitreal cavity with BSS solution; at average severity from 80 to 149 f/ms – tamponade of vitreal cavity with perfluoroorganic compound to 14 days or tamponade of vitreal cavity with silicone oil provided complete removal of exudate of vitreal cavity; at severe severity from 150 and higher f/ms – tamponade of vitreal cavity with perfluoroorganic compound till 14 days, with subsequent replacement with silicone oil.EFFECT: method provides reducing an inflammatory reaction of the eye with minimal traumatisation of eye structures from the surgical intervention as a result of a differentiated approach to treating acute postoperative endophthalmitis depending on endophthalmitis initial severity determined by laser tindalemetry.1 cl, 3 ex |
| priorityDate | 2018-11-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 36.